Oncolytics Biotech Inc. ONCY
0.39 USD -0.01 (-2.50%)
At closeNov 3, 2026, 4:21 PM EST
0.38 -0.01 -1.54%
After hours · Nov 3, 4:21 PM ET
0.3816 Day range 0.4072
0.3816 52-week range 1.30
- YTD
- -55.17%
- 1 year
- -64.22%
Analyst view
Price target (mean) 4.85
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy5
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.1345 | -0.139 – -0.13 | -0.111 | -21.2% | 0 | 0.0% | 2 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -0.40667 | -0.43 – -0.38 | -0.489 | +16.8% | 0 | 0.0% | 3 |
| Next year | -0.4665 | -0.54 – -0.36 | -0.40667 | -14.7% | 857.14K | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 21, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 4, 2024 | Raymond James | Initiated | — | Outperform |
| Mar 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 4, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 13, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 16, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 29, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 23, 2023 | Canaccord Genuity | Reiterated | Buy | Buy |
| Jun 7, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 26, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 24, 2023 | JonesTrading | Initiated | — | Buy |
| Mar 14, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 6, 2023 | Canaccord Genuity | Maintained | — | Buy |
| Oct 6, 2022 | Maxim Group | Initiated | — | Buy |
| Feb 17, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| May 11, 2020 | RBC Capital | Maintained | — | Outperform |
| Sep 12, 2013 | Needham | Initiated | — | Buy |
| Mar 4, 2013 | Piper Sandler | Initiated | — | Overweight |
| Dec 18, 2012 | Bloom Burton & Co. | Downgrade | Buy | Hold |
| Sep 12, 2012 | Bloom Burton & Co. | Maintained | — | Buy |
| Aug 30, 2012 | Stifel | Initiated | — | Buy |